Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail

Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Daniella Brasacchio 1 , Jun Okabe 1 , Christos Tikellis 2 , Aneta Balcerczyk 1 , Prince George 1 , Emma K. Baker 1 , Anna C. Cal...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 58; no. 5; pp. 1229 - 1236
Main Authors Brasacchio, Daniella, Okabe, Jun, Tikellis, Christos, Balcerczyk, Aneta, George, Prince, Baker, Emma K., Calkin, Anna C., Brownlee, Michael, Cooper, Mark E., El-Osta, Assam
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.05.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Daniella Brasacchio 1 , Jun Okabe 1 , Christos Tikellis 2 , Aneta Balcerczyk 1 , Prince George 1 , Emma K. Baker 1 , Anna C. Calkin 2 , Michael Brownlee 3 , Mark E. Cooper 2 , 3 and Assam El-Osta 1 1 Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia; 2 Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and 3 JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York. Corresponding author: Assam El-Osta, assam.el-osta{at}bakeridi.edu.au . Abstract OBJECTIVE Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as “hyperglycemic memory.” We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. RESEARCH DESIGN AND METHODS Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFκB-p65 chromatin. RESULTS The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. CONCLUSIONS These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received December 2, 2008. Accepted February 3, 2009. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. © 2009 by the American Diabetes Association.
AbstractList Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information.OBJECTIVEResults from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information.Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin.RESEARCH DESIGN AND METHODSModels of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin.The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia.RESULTSThe sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia.These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.CONCLUSIONSThese studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.
Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin. The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.
Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Daniella Brasacchio 1 , Jun Okabe 1 , Christos Tikellis 2 , Aneta Balcerczyk 1 , Prince George 1 , Emma K. Baker 1 , Anna C. Calkin 2 , Michael Brownlee 3 , Mark E. Cooper 2 , 3 and Assam El-Osta 1 1 Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia; 2 Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and 3 JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York. Corresponding author: Assam El-Osta, assam.el-osta{at}bakeridi.edu.au . Abstract OBJECTIVE Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as “hyperglycemic memory.” We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. RESEARCH DESIGN AND METHODS Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFκB-p65 chromatin. RESULTS The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. CONCLUSIONS These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received December 2, 2008. Accepted February 3, 2009. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. © 2009 by the American Diabetes Association.
OBJECTIVE--Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects cow tinued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. RESEARCH DESIGN AND METHODS--Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demetho ylase (LSD1) by the immunopurification of soluble NFκBop65 chromatin. RESULTS--The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4ml but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. CONCLUSIONS--These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.
Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin. The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.
Audience Professional
Author Assam El-Osta
Christos Tikellis
Emma K. Baker
Anna C. Calkin
Daniella Brasacchio
Prince George
Aneta Balcerczyk
Jun Okabe
Mark E. Cooper
Michael Brownlee
Author_xml – sequence: 1
  givenname: Daniella
  surname: Brasacchio
  fullname: Brasacchio, Daniella
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
– sequence: 2
  givenname: Jun
  surname: Okabe
  fullname: Okabe, Jun
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
– sequence: 3
  givenname: Christos
  surname: Tikellis
  fullname: Tikellis, Christos
  organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and
– sequence: 4
  givenname: Aneta
  surname: Balcerczyk
  fullname: Balcerczyk, Aneta
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
– sequence: 5
  givenname: Prince
  surname: George
  fullname: George, Prince
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
– sequence: 6
  givenname: Emma K.
  surname: Baker
  fullname: Baker, Emma K.
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
– sequence: 7
  givenname: Anna C.
  surname: Calkin
  fullname: Calkin, Anna C.
  organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and
– sequence: 8
  givenname: Michael
  surname: Brownlee
  fullname: Brownlee, Michael
  organization: JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York
– sequence: 9
  givenname: Mark E.
  surname: Cooper
  fullname: Cooper, Mark E.
  organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and, JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York
– sequence: 10
  givenname: Assam
  surname: El-Osta
  fullname: El-Osta, Assam
  organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21457652$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19208907$$D View this record in MEDLINE/PubMed
BookMark eNp9k11v0zAUhiM0xD7ggj-ALBBICGXzR5vEN0hVN9ZJnXYzBHeW65ykHqldYncs_CX-JCdq6SiqkC-SOM953-Nzjo-TA-cdJMlLRk-5EPlZOaNFyrIse5IcMSlkKnj-9SA5opTxlOUyP0yOQ7ijlGa4niWHTHJaSJofJb8m3RLauukMLKwmV65cGQhEk_PO6YU1ZOw9Ajraexs74isysSGiPbmGOO8aHYBoV5JzWGy_L9zPboEioxC8sTpCSb7YOCeX4CAdGZRCOVeTi6WtcSuiy7VuvwVyO9cRDeEBLYh3JM6BTLtg0e1W2-Z58rTSTYAXm-dJ8vnTxe14kk5vLq_Go2lqsoGIqYEZlwY403wGlShoVvBqRplkhcmGnBUiG2rOZFbMYEjpoBzAUBjKBkYywSATJ8nHte5yNVtAacDFVjdq2dqFbjvltVW7f5ydq9rfK57ljIoCBd5tBFr_fQUhqoUNBppGO_CroBDLpeC90-t_wDu_ah0eTnGWDSTDNBF6s4Zq3YCyrvJoanpFNWJSDjIhC4FUuofq64sZYr8qi9s7_OkeHleJg2D2BrzfCUAmwkOs9SoEVVxO_5fMhjW-aaAGhd0a3-zyr_6u-LbUf-YUgbcbQAejm6rVztiw5TgbDHPsLXJna860PoQWKmVsxGnzfaNsoxhV_Y1R_Y1R_Y15PNY2Ymu-h_2wZue2nv-wLajS6hlECI8vw0INFeNcit9Y7CNF
CODEN DIAEAZ
CitedBy_id crossref_primary_10_1089_jir_2014_0172
crossref_primary_10_1016_j_freeradbiomed_2017_12_017
crossref_primary_10_1016_j_intimp_2024_111558
crossref_primary_10_1155_2017_2608605
crossref_primary_10_3390_cells10102548
crossref_primary_10_3390_genes13040705
crossref_primary_10_1161_JAHA_118_010012
crossref_primary_10_1093_cvr_cvac058
crossref_primary_10_1139_cjpp_2012_0251
crossref_primary_10_1016_j_smim_2016_04_004
crossref_primary_10_1093_nar_gkw621
crossref_primary_10_1172_JCI61084
crossref_primary_10_1002_dmrr_1281
crossref_primary_10_2337_db13_1251
crossref_primary_10_1002_dmrr_2375
crossref_primary_10_1146_annurev_immunol_102119_073855
crossref_primary_10_1016_j_biocel_2016_06_021
crossref_primary_10_1016_j_molonc_2012_07_004
crossref_primary_10_1016_j_atherosclerosis_2013_07_003
crossref_primary_10_1007_s11892_018_0979_3
crossref_primary_10_3390_ijms21228462
crossref_primary_10_1210_me_2013_1293
crossref_primary_10_1161_HYPERTENSIONAHA_114_04585
crossref_primary_10_3390_molecules23030567
crossref_primary_10_3389_fphys_2021_640700
crossref_primary_10_1016_j_diabres_2011_05_033
crossref_primary_10_1007_s00424_010_0807_3
crossref_primary_10_1681_ASN_0000000000000345
crossref_primary_10_1155_2014_654148
crossref_primary_10_1007_s11427_014_4710_6
crossref_primary_10_1007_s13679_022_00477_x
crossref_primary_10_1002_dmrr_1037
crossref_primary_10_1038_labinvest_2013_47
crossref_primary_10_1097_MD_0000000000016317
crossref_primary_10_1161_CIRCRESAHA_116_303936
crossref_primary_10_3390_toxins10100410
crossref_primary_10_1016_j_neulet_2016_04_046
crossref_primary_10_1186_s12933_024_02196_0
crossref_primary_10_3390_nu8080486
crossref_primary_10_1038_s41598_018_34612_3
crossref_primary_10_2337_db12_1648
crossref_primary_10_3390_ijms21176275
crossref_primary_10_1016_j_bbadis_2018_09_032
crossref_primary_10_1161_CIRCRESAHA_115_306341
crossref_primary_10_1186_ar4564
crossref_primary_10_1210_me_2011_1157
crossref_primary_10_1016_j_canlet_2016_02_006
crossref_primary_10_1016_j_pharmthera_2010_10_003
crossref_primary_10_1155_2021_7887426
crossref_primary_10_1016_j_diabres_2014_03_019
crossref_primary_10_1016_j_mce_2013_04_002
crossref_primary_10_1016_j_xkme_2020_10_005
crossref_primary_10_3389_fcell_2021_777258
crossref_primary_10_1016_j_dsx_2018_07_001
crossref_primary_10_1080_15592294_2016_1278097
crossref_primary_10_2337_dbi18_0010
crossref_primary_10_1042_CS20120413
crossref_primary_10_1186_s13148_015_0090_4
crossref_primary_10_1155_2013_589474
crossref_primary_10_1017_S0954422411000102
crossref_primary_10_1515_hmbci_2016_0022
crossref_primary_10_1586_eem_10_76
crossref_primary_10_1016_S1957_2557_15_30008_0
crossref_primary_10_1093_cvr_cvr024
crossref_primary_10_2174_1573399818666220422085016
crossref_primary_10_1161_CIRCRESAHA_112_268375
crossref_primary_10_1186_s13148_020_00826_4
crossref_primary_10_3727_096368914X682792
crossref_primary_10_2174_0115733998279869231227091944
crossref_primary_10_1007_s00018_013_1299_z
crossref_primary_10_1155_2010_437809
crossref_primary_10_1155_2020_3818196
crossref_primary_10_3390_nu14020320
crossref_primary_10_2337_db17_0294
crossref_primary_10_1016_j_bcp_2010_06_005
crossref_primary_10_1210_en_2013_1097
crossref_primary_10_1371_journal_pone_0123987
crossref_primary_10_1007_s00005_014_0271_4
crossref_primary_10_3390_ijms23094589
crossref_primary_10_1007_s12015_012_9398_z
crossref_primary_10_1016_j_yjmcc_2019_06_010
crossref_primary_10_1007_s00246_019_02160_w
crossref_primary_10_1038_nrendo_2010_188
crossref_primary_10_1089_ars_2015_6372
crossref_primary_10_3390_nu15040811
crossref_primary_10_1038_srep00081
crossref_primary_10_3389_fcell_2022_839109
crossref_primary_10_3390_ijms222111857
crossref_primary_10_1161_CIRCULATIONAHA_111_033274
crossref_primary_10_1681_ASN_2014070678
crossref_primary_10_1007_s11356_023_25236_w
crossref_primary_10_1089_ars_2017_7347
crossref_primary_10_1038_pr_2013_224
crossref_primary_10_3390_ijms20194873
crossref_primary_10_1038_jhg_2013_57
crossref_primary_10_1016_j_tem_2016_09_003
crossref_primary_10_3390_biom11121779
crossref_primary_10_1042_CS20150093
crossref_primary_10_1016_j_gene_2012_09_090
crossref_primary_10_1111_febs_12938
crossref_primary_10_1016_S2213_8587_14_70155_X
crossref_primary_10_2337_dbi20_0030
crossref_primary_10_2217_pme_15_17
crossref_primary_10_1016_j_biochi_2020_01_007
crossref_primary_10_1016_j_isci_2023_106917
crossref_primary_10_1016_j_krcp_2012_07_004
crossref_primary_10_1113_JP271913
crossref_primary_10_1155_2012_481840
crossref_primary_10_1530_JOE_15_0469
crossref_primary_10_1038_s41598_021_81794_4
crossref_primary_10_3390_jcm11123369
crossref_primary_10_3109_07853890_2013_857259
crossref_primary_10_26508_lsa_202302382
crossref_primary_10_1007_s00125_017_4490_1
crossref_primary_10_3389_fimmu_2020_00315
crossref_primary_10_1097_MCO_0b013e328338aa61
crossref_primary_10_1517_14728222_2011_561786
crossref_primary_10_4137_GEG_S12270
crossref_primary_10_3390_ijms19051456
crossref_primary_10_3892_mmr_2018_9142
crossref_primary_10_3945_ajcn_110_000927
crossref_primary_10_1016_j_yjmcc_2021_05_018
crossref_primary_10_2337_db16_0254
crossref_primary_10_1016_j_biochi_2022_08_001
crossref_primary_10_1074_jbc_M111_330373
crossref_primary_10_1016_j_vaccine_2021_04_011
crossref_primary_10_1021_cb500785t
crossref_primary_10_1016_j_bbrc_2020_05_075
crossref_primary_10_1155_2021_5544518
crossref_primary_10_2337_db11_0588
crossref_primary_10_3389_fendo_2021_679655
crossref_primary_10_3389_fendo_2023_1119765
crossref_primary_10_1016_j_urolonc_2024_09_007
crossref_primary_10_1038_ki_2010_335
crossref_primary_10_1002_glia_22405
crossref_primary_10_1155_2016_4065382
crossref_primary_10_1016_j_bbrc_2013_02_064
crossref_primary_10_2478_fzm_2022_0030
crossref_primary_10_1007_s11428_023_01020_9
crossref_primary_10_1038_ncomms1755
crossref_primary_10_1152_ajprenal_00697_2012
crossref_primary_10_1159_000357824
crossref_primary_10_3390_biomedicines9111596
crossref_primary_10_1089_scd_2013_0125
crossref_primary_10_1007_s11892_017_0916_x
crossref_primary_10_1016_j_jdiacomp_2015_07_015
crossref_primary_10_1007_s10719_021_10031_x
crossref_primary_10_3390_nu9050437
crossref_primary_10_1007_s11356_021_13862_1
crossref_primary_10_1016_S2213_8587_21_00245_X
crossref_primary_10_1042_BCJ20160595
crossref_primary_10_1016_j_jdiacomp_2018_08_012
crossref_primary_10_2353_ajpath_2010_090528
crossref_primary_10_1186_1475_2840_12_96
crossref_primary_10_1186_s13148_024_01667_1
crossref_primary_10_1007_s12041_013_0288_1
crossref_primary_10_1186_s13148_019_0632_2
crossref_primary_10_1177_1479164113500680
crossref_primary_10_1371_journal_pone_0109663
crossref_primary_10_3109_0886022X_2014_1000801
crossref_primary_10_3389_fcvm_2020_570553
crossref_primary_10_1038_s41573_019_0025_4
crossref_primary_10_1101_gr_116095_110
crossref_primary_10_1016_j_bbrc_2012_07_105
crossref_primary_10_1038_cdd_2016_119
crossref_primary_10_1097_FJC_0000000000001516
crossref_primary_10_1152_ajprenal_00237_2010
crossref_primary_10_1097_CM9_0000000000001450
crossref_primary_10_1002_cmdc_201402091
crossref_primary_10_3390_ijms19124061
crossref_primary_10_4093_dmj_2014_38_5_330
crossref_primary_10_1097_MOL_0b013e32834f319d
crossref_primary_10_1038_nature12752
crossref_primary_10_1007_s00592_019_01363_0
crossref_primary_10_1016_j_pbiomolbio_2015_02_010
crossref_primary_10_1139_bcb_2015_0057
crossref_primary_10_1053_j_jvca_2016_02_008
crossref_primary_10_1155_2010_263914
crossref_primary_10_3389_fendo_2018_00002
crossref_primary_10_1007_s00018_016_2316_9
crossref_primary_10_1007_s12016_016_8592_1
crossref_primary_10_1016_j_clim_2014_12_013
crossref_primary_10_1096_fj_201901358RR
crossref_primary_10_1016_j_biocel_2014_04_014
crossref_primary_10_17343_sdutfd_1273169
crossref_primary_10_1146_annurev_nutr_121214_104422
crossref_primary_10_1038_nrdp_2015_18
crossref_primary_10_2337_db10_0133
crossref_primary_10_31083_j_fbl2809194
crossref_primary_10_30629_0023_2149_2024_102_2_109_117
crossref_primary_10_1007_s12265_012_9380_9
crossref_primary_10_1038_s42003_022_03225_y
crossref_primary_10_3389_fendo_2023_1128622
crossref_primary_10_1152_physrev_00045_2011
crossref_primary_10_3389_fphys_2022_952445
crossref_primary_10_2337_db09_1003
crossref_primary_10_1021_jm501234a
crossref_primary_10_2337_db11_0416
crossref_primary_10_1038_s41581_019_0135_6
crossref_primary_10_1155_2017_9702820
crossref_primary_10_1038_nrendo_2014_29
crossref_primary_10_1042_BSR20202160
crossref_primary_10_3389_fphar_2022_885527
crossref_primary_10_1089_ars_2017_7310
crossref_primary_10_1016_j_tem_2014_08_006
crossref_primary_10_3390_biomedicines12091958
crossref_primary_10_1089_ars_2017_7318
crossref_primary_10_1007_s00125_014_3462_y
crossref_primary_10_1681_ASN_2010060633
crossref_primary_10_1126_science_aaf1098
crossref_primary_10_1186_s13148_015_0068_2
crossref_primary_10_1161_CIRCULATIONAHA_111_025270
crossref_primary_10_3389_fimmu_2023_1183066
crossref_primary_10_3945_an_113_004705
crossref_primary_10_1152_physrev_00031_2021
crossref_primary_10_1038_icb_2014_105
crossref_primary_10_3390_ijms20122949
crossref_primary_10_1152_ajpcell_00011_2020
crossref_primary_10_1016_j_bbrc_2015_10_030
crossref_primary_10_1038_ki_2011_39
crossref_primary_10_1016_j_chom_2010_02_005
crossref_primary_10_1177_09636897231198167
crossref_primary_10_1111_1753_0407_13372
crossref_primary_10_3390_genes6010087
crossref_primary_10_1152_ajpendo_00105_2011
crossref_primary_10_3390_ijms222413378
crossref_primary_10_1016_j_dsx_2016_08_007
crossref_primary_10_3389_fimmu_2022_883410
crossref_primary_10_1007_s40618_014_0172_8
crossref_primary_10_1007_s00018_017_2635_5
crossref_primary_10_1152_ajprenal_00115_2024
crossref_primary_10_1016_j_semcancer_2020_11_019
crossref_primary_10_1155_2015_409432
crossref_primary_10_1186_s43042_024_00595_2
crossref_primary_10_1194_jlr_M002782
crossref_primary_10_4103_jpbs_JPBS_771_20
crossref_primary_10_1007_s10741_013_9381_z
crossref_primary_10_1080_14728222_2019_1696309
crossref_primary_10_1016_j_bcp_2010_07_029
crossref_primary_10_1097_MED_0b013e328339f31e
crossref_primary_10_1007_s11859_013_0886_z
crossref_primary_10_1371_journal_pone_0135218
crossref_primary_10_1016_j_lfs_2022_120490
crossref_primary_10_1152_ajpcell_00201_2022
crossref_primary_10_1155_2016_6927234
crossref_primary_10_1007_s00125_010_1967_6
crossref_primary_10_1080_00325481_2019_1681215
crossref_primary_10_1093_eurheartj_ehaa857
crossref_primary_10_1172_JCI72271
crossref_primary_10_3109_10715762_2013_789136
crossref_primary_10_1089_ars_2011_4381
crossref_primary_10_3389_fimmu_2020_631743
crossref_primary_10_1161_HYPERTENSIONAHA_123_22483
crossref_primary_10_1371_journal_pone_0233639
crossref_primary_10_3389_fimmu_2019_01330
crossref_primary_10_1515_cclm_2017_0982
crossref_primary_10_1016_j_ajpath_2015_05_003
crossref_primary_10_1016_j_cmet_2010_09_004
crossref_primary_10_3390_ijms21051835
crossref_primary_10_1007_s11892_015_0677_3
crossref_primary_10_4161_epi_6_7_16551
crossref_primary_10_1002_mnfr_201900480
crossref_primary_10_1155_2018_2931049
crossref_primary_10_1016_j_pharmthera_2014_01_003
crossref_primary_10_1038_nrneph_2010_55
crossref_primary_10_1016_j_atherosclerosis_2017_09_003
crossref_primary_10_1016_j_chembiol_2010_11_014
crossref_primary_10_1016_j_ctrv_2018_08_004
crossref_primary_10_1155_2017_2712751
crossref_primary_10_2147_DMSO_S288500
crossref_primary_10_3389_fphar_2019_00666
crossref_primary_10_1007_s00018_018_2864_2
crossref_primary_10_1093_burnst_tkac057
crossref_primary_10_1016_j_molmet_2020_01_019
crossref_primary_10_1016_j_nut_2014_07_017
crossref_primary_10_1007_s00441_017_2588_x
crossref_primary_10_1111_jcmm_18158
crossref_primary_10_3390_jcm8091329
crossref_primary_10_1007_s11684_021_0881_2
crossref_primary_10_1161_CIRCRESAHA_112_266171
crossref_primary_10_1016_j_cell_2017_12_013
crossref_primary_10_2217_pme_2017_0043
crossref_primary_10_1016_j_hlc_2010_07_013
crossref_primary_10_1155_2015_436879
crossref_primary_10_1007_s00018_014_1651_y
crossref_primary_10_1016_j_jhep_2011_10_018
crossref_primary_10_1007_s12016_016_8534_y
crossref_primary_10_1016_j_mam_2012_06_010
crossref_primary_10_2337_db14_0238
crossref_primary_10_1016_j_atherosclerosis_2016_12_007
crossref_primary_10_1152_physrev_00004_2012
crossref_primary_10_2337_db10_0208
crossref_primary_10_17795_jpr_3375
crossref_primary_10_1186_1868_7083_5_15
crossref_primary_10_2337_db11_0073
crossref_primary_10_2337_db14_0231
crossref_primary_10_1186_s40001_024_02069_y
crossref_primary_10_21886_2712_8156_2022_3_2_7_18
crossref_primary_10_1007_s11892_012_0302_7
crossref_primary_10_1111_j_1440_1681_2011_05497_x
crossref_primary_10_1016_j_semnephrol_2010_07_004
crossref_primary_10_1098_rsob_120173
crossref_primary_10_1016_j_fertnstert_2013_11_033
crossref_primary_10_3390_ijms19041224
crossref_primary_10_1161_CIRCRESAHA_110_223552
crossref_primary_10_1016_j_trsl_2017_05_002
crossref_primary_10_1152_ajprenal_00200_2010
crossref_primary_10_3389_fgene_2022_957937
crossref_primary_10_1002_biof_1306
crossref_primary_10_3390_antiox10111849
crossref_primary_10_1016_j_cmet_2017_02_006
crossref_primary_10_1016_j_mam_2016_09_004
crossref_primary_10_1080_15592294_2020_1748918
crossref_primary_10_4239_wjd_v12_i8_1200
crossref_primary_10_1152_ajprenal_00029_2017
crossref_primary_10_1096_fj_201601116R
crossref_primary_10_1161_CIRCRESAHA_110_223545
crossref_primary_10_1155_2015_373708
crossref_primary_10_1161_CIRCRESAHA_116_306819
crossref_primary_10_1016_j_cmet_2011_11_007
crossref_primary_10_1016_j_survophthal_2020_02_005
crossref_primary_10_1517_14712598_2012_641531
crossref_primary_10_1186_s13148_025_01842_y
crossref_primary_10_1016_j_jash_2010_02_004
crossref_primary_10_1038_s41419_020_2350_2
crossref_primary_10_1053_j_ackd_2014_03_004
crossref_primary_10_2337_db12_1141
crossref_primary_10_1016_j_ecl_2016_07_001
crossref_primary_10_1016_j_carpath_2012_07_004
crossref_primary_10_1007_s11892_016_0723_9
crossref_primary_10_1016_j_drudis_2023_103754
crossref_primary_10_1038_nrd3674
crossref_primary_10_3389_fcvm_2023_1164499
crossref_primary_10_1016_j_smim_2016_09_002
crossref_primary_10_1007_s00467_010_1714_8
crossref_primary_10_1586_eem_09_54
crossref_primary_10_1371_journal_pone_0154939
crossref_primary_10_1007_s10787_019_00663_9
crossref_primary_10_1155_2014_789120
crossref_primary_10_1007_s11892_013_0383_y
crossref_primary_10_1016_j_imbio_2016_08_011
crossref_primary_10_17116_terarkh2016881035_41
crossref_primary_10_1016_j_it_2018_11_002
crossref_primary_10_1155_2019_7495629
crossref_primary_10_1038_s41392_024_01755_x
crossref_primary_10_4161_epi_24234
crossref_primary_10_1039_C4FO00803K
crossref_primary_10_1016_j_tem_2009_10_002
crossref_primary_10_1111_dom_12688
crossref_primary_10_1080_15592294_2023_2201714
crossref_primary_10_1016_S0001_4079_19_32060_6
crossref_primary_10_1371_journal_pone_0143814
crossref_primary_10_1186_s12933_024_02195_1
crossref_primary_10_1016_j_celrep_2020_107548
crossref_primary_10_1016_j_lfs_2015_02_022
crossref_primary_10_1111_cge_12121
crossref_primary_10_1371_journal_pone_0015960
crossref_primary_10_1038_srep40544
crossref_primary_10_1161_ATVBAHA_124_321446
crossref_primary_10_1016_j_jdiacomp_2018_01_015
crossref_primary_10_1007_s00018_014_1816_8
Cites_doi 10.1161/01.CIR.0000124061.78478.94
10.1056/NEJMoa0802987
10.1084/jem.20081188
10.1038/nature01550
10.1038/nature04853
10.1016/j.cell.2004.12.012
10.2337/diabetes.54.3.830
10.1056/NEJMoa0802743
10.1016/j.molcel.2007.02.023
10.1001/jama.290.16.2159
10.1016/j.cell.2006.03.027
10.1056/NEJMoa0806470
10.1038/ncb1546
10.1016/S1097-2765(01)00405-1
10.1038/nsmb0407-252
10.1038/nature04020
10.1161/CIRCRESAHA.108.175190
10.1038/nature01378
10.1161/01.RES.0000266449.37396.1f
10.1073/pnas.87.1.404
10.1016/j.cell.2006.04.003
10.1681/ASN.2005010013
10.1038/nature04433
10.1056/NEJMoa052187
10.1093/hmg/ddh032
10.1073/pnas.1834876100
10.1016/j.molcel.2006.12.014
10.1056/NEJMe0807625
10.1161/CIRCRESAHA.108.184358
10.1161/01.CIR.0000021122.63813.32
10.1055/s-0029-1210861
10.1007/BF02341509
ContentType Journal Article
Copyright 2009 INIST-CNRS
COPYRIGHT 2009 American Diabetes Association
Copyright American Diabetes Association May 2009
2009 by the American Diabetes Association. 2009
Copyright_xml – notice: 2009 INIST-CNRS
– notice: COPYRIGHT 2009 American Diabetes Association
– notice: Copyright American Diabetes Association May 2009
– notice: 2009 by the American Diabetes Association. 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
5PM
DOI 10.2337/db08-1666
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Research Library Prep

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 1236
ExternalDocumentID PMC2671038
1777478541
A199463983
19208907
21457652
10_2337_db08_1666
diabetes_58_5_1229
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States
United Kingdom--UK
GeographicLocations_xml – name: United States
– name: United Kingdom--UK
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
53G
55
5GY
5RE
5RS
5VS
7RV
7X7
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ABUWG
ACDCL
ACGOD
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EX3
F5P
FRP
FYUFA
GICCO
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
H~9
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
K-O
K9-
KM
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5
M7P
MBDVC
O0-
O5R
O5S
O9-
OB3
OBH
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
WH7
WOQ
WOW
X7M
XZ
ZA5
ZY1
---
.55
.GJ
.XZ
08P
0R~
18M
354
6PF
AAFWJ
AAKAS
AAYOK
AAYXX
ACGFO
ADGHP
ADZCM
AEGXH
AERZD
AIAGR
AIZAD
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
ITC
K2M
M5~
N4W
NAPCQ
OHH
PHGZM
PHGZT
TEORI
TR2
UKHRP
VVN
W8F
YFH
YHG
YOC
~KM
1CY
8F7
AFFNX
AI.
IQODW
J5H
MVM
PJZUB
PPXIY
PQGLB
VH1
XOL
YQJ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PKEHL
Q9U
7X8
5PM
ID FETCH-LOGICAL-c643t-ceb29ce21a2bef380682fb01918c65218365a21968be5004d4e53c014c9131e63
IEDL.DBID 7X7
ISSN 0012-1797
1939-327X
IngestDate Thu Aug 21 14:27:02 EDT 2025
Thu Jul 10 22:24:57 EDT 2025
Fri Jul 25 10:44:51 EDT 2025
Tue Jun 17 21:57:39 EDT 2025
Thu Jun 12 23:57:54 EDT 2025
Tue Jun 10 20:58:34 EDT 2025
Fri Jun 27 05:16:43 EDT 2025
Tue Jun 10 19:56:16 EDT 2025
Mon Jul 21 05:16:43 EDT 2025
Mon Jul 21 09:14:19 EDT 2025
Thu Apr 24 22:53:30 EDT 2025
Tue Jul 01 03:04:01 EDT 2025
Fri Jan 15 19:45:48 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Endocrinopathy
Hyperglycemia
Gene
Enzyme
Lysine
Aminoacid
Diabetes mellitus
Tail
Epigenetics
Histone
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c643t-ceb29ce21a2bef380682fb01918c65218365a21968be5004d4e53c014c9131e63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2671038
PMID 19208907
PQID 216491219
PQPubID 34443
PageCount 8
ParticipantIDs crossref_citationtrail_10_2337_db08_1666
gale_infotracgeneralonefile_A199463983
pubmed_primary_19208907
gale_incontextgauss_8GL_A199463983
proquest_miscellaneous_67179326
proquest_journals_216491219
gale_infotracmisc_A199463983
gale_infotracacademiconefile_A199463983
highwire_diabetes_diabetes_58_5_1229
pascalfrancis_primary_21457652
gale_incontextcollege_GICCO_A199463983
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2671038
crossref_primary_10_2337_db08_1666
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-05-01
PublicationDateYYYYMMDD 2009-05-01
PublicationDate_xml – month: 05
  year: 2009
  text: 2009-05-01
  day: 01
PublicationDecade 2000
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2009
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Nathan (2022031209283954800_B2) 2005; 353
Wang (2022031209283954800_B14) 2001; 8
Reddy (2022031209283954800_B26) 2008; 103
Trojer (2022031209283954800_B18) 2006; 125
Lake (2022031209283954800_B32) 1988; 31
Lan (2022031209283954800_B23) 2007; 26
Kennedy (2022031209283954800_B28) 2005; 54
Candido (2022031209283954800_B11) 2002; 106
Klose (2022031209283954800_B24) 2006; 442
Mack (2022031209283954800_B8) 2008; 103
Gerstein (2022031209283954800_B6) 2008; 358
Metzger (2022031209283954800_B19) 2005; 437
Candido (2022031209283954800_B29) 2004; 109
Akagi (2022031209283954800_B10) 2003; 100
Thomas (2022031209283954800_B12) 2005; 16
Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2022031209283954800_B1) 2003; 290
Chalmers (2022031209283954800_B4) 2008; 359
Hartmann (2022031209283954800_B31) 1989; 93
Shi (2022031209283954800_B16) 2003; 422
Holman (2022031209283954800_B30) 2008; 359
Wissmann (2022031209283954800_B21) 2007; 9
Hsueh (2022031209283954800_B27) 2007; 100
Shi (2022031209283954800_B20) 2004; 119
El-Osta (2022031209283954800_B3) 2008; 205
Roy (2022031209283954800_B7) 1990; 87
Yamane (2022031209283954800_B25) 2006; 125
Patel (2022031209283954800_B5) 2008; 358
Xiao (2022031209283954800_B13) 2003; 421
Tsukada (2022031209283954800_B22) 2006; 439
Okabe (2022031209283954800_B9) 2004; 13
Ruthenburg (2022031209283954800_B15) 2007; 25
Metzger (2022031209283954800_B17) 2007; 14
12700765 - Nature. 2003 Apr 17;422(6933):735-8
2528469 - Exp Clin Endocrinol. 1989 May;93(2-3):225-30
16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53
18796642 - Circ Res. 2008 Sep 12;103(6):568-70
16630806 - Cell. 2006 Apr 21;125(2):213-7
3138150 - Diabetologia. 1988 Jun;31(6):390-4
12105166 - Circulation. 2002 Jul 9;106(2):246-53
15023892 - Circulation. 2004 Mar 30;109(12):1536-42
17525381 - Circ Res. 2007 May 25;100(10):1415-27
18809715 - J Exp Med. 2008 Sep 29;205(10):2409-17
18843126 - N Engl J Med. 2008 Oct 9;359(15):1618-20
16079795 - Nature. 2005 Sep 15;437(7057):436-9
16603237 - Cell. 2006 May 5;125(3):483-95
18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59
12540855 - Nature. 2003 Feb 6;421(6923):652-6
15620353 - Cell. 2004 Dec 29;119(7):941-53
17410086 - Nat Struct Mol Biol. 2007 Apr;14(4):252-4
18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89
16362057 - Nature. 2006 Feb 16;439(7078):811-6
18688044 - Circ Res. 2008 Sep 12;103(6):615-23
11779497 - Mol Cell. 2001 Dec;8(6):1207-17
16107577 - J Am Soc Nephrol. 2005 Oct;16(10):2976-84
17434129 - Mol Cell. 2007 Apr 13;26(1):89-101
18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72
2296596 - Proc Natl Acad Sci U S A. 1990 Jan;87(1):404-8
14597713 - Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13567-72
17218268 - Mol Cell. 2007 Jan 12;25(1):15-30
16732292 - Nature. 2006 Jul 20;442(7100):312-6
14681297 - Hum Mol Genet. 2004 Feb 1;13(3):285-93
17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53
14570951 - JAMA. 2003 Oct 22;290(16):2159-67
15734862 - Diabetes. 2005 Mar;54(3):830-7
References_xml – volume: 109
  start-page: 1536
  year: 2004
  ident: 2022031209283954800_B29
  article-title: Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000124061.78478.94
– volume: 358
  start-page: 2560
  year: 2008
  ident: 2022031209283954800_B5
  article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802987
– volume: 205
  start-page: 2409
  year: 2008
  ident: 2022031209283954800_B3
  article-title: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
  publication-title: J Exp Med
  doi: 10.1084/jem.20081188
– volume: 422
  start-page: 735
  year: 2003
  ident: 2022031209283954800_B16
  article-title: Coordinated histone modifications mediated by a CtBP co-repressor complex
  publication-title: Nature
  doi: 10.1038/nature01550
– volume: 442
  start-page: 312
  year: 2006
  ident: 2022031209283954800_B24
  article-title: The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36
  publication-title: Nature
  doi: 10.1038/nature04853
– volume: 119
  start-page: 941
  year: 2004
  ident: 2022031209283954800_B20
  article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.012
– volume: 54
  start-page: 830
  year: 2005
  ident: 2022031209283954800_B28
  article-title: Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.3.830
– volume: 358
  start-page: 2545
  year: 2008
  ident: 2022031209283954800_B6
  article-title: Effects of intensive glucose lowering in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802743
– volume: 26
  start-page: 89
  year: 2007
  ident: 2022031209283954800_B23
  article-title: S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2007.02.023
– volume: 290
  start-page: 2159
  year: 2003
  ident: 2022031209283954800_B1
  article-title: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy
  publication-title: JAMA
  doi: 10.1001/jama.290.16.2159
– volume: 125
  start-page: 483
  year: 2006
  ident: 2022031209283954800_B25
  article-title: JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor
  publication-title: Cell
  doi: 10.1016/j.cell.2006.03.027
– volume: 359
  start-page: 1577
  year: 2008
  ident: 2022031209283954800_B30
  article-title: 10-year follow-up of intensive glucose control in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0806470
– volume: 9
  start-page: 347
  year: 2007
  ident: 2022031209283954800_B21
  article-title: Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1546
– volume: 8
  start-page: 1207
  year: 2001
  ident: 2022031209283954800_B14
  article-title: Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(01)00405-1
– volume: 14
  start-page: 252
  year: 2007
  ident: 2022031209283954800_B17
  article-title: The expanding world of histone lysine demethylases
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb0407-252
– volume: 437
  start-page: 436
  year: 2005
  ident: 2022031209283954800_B19
  article-title: LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
  publication-title: Nature
  doi: 10.1038/nature04020
– volume: 103
  start-page: 615
  year: 2008
  ident: 2022031209283954800_B26
  article-title: Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.175190
– volume: 421
  start-page: 652
  year: 2003
  ident: 2022031209283954800_B13
  article-title: Structure and catalytic mechanism of the human histone methyltransferase SET7/9
  publication-title: Nature
  doi: 10.1038/nature01378
– volume: 100
  start-page: 1415
  year: 2007
  ident: 2022031209283954800_B27
  article-title: Recipes for creating animal models of diabetic cardiovascular disease
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000266449.37396.1f
– volume: 87
  start-page: 404
  year: 1990
  ident: 2022031209283954800_B7
  article-title: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.87.1.404
– volume: 125
  start-page: 213
  year: 2006
  ident: 2022031209283954800_B18
  article-title: Histone lysine demethylases and their impact on epigenetics
  publication-title: Cell
  doi: 10.1016/j.cell.2006.04.003
– volume: 16
  start-page: 2976
  year: 2005
  ident: 2022031209283954800_B12
  article-title: Interactions between renin angiotensin system and advanced glycation in the kidney
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005010013
– volume: 439
  start-page: 811
  year: 2006
  ident: 2022031209283954800_B22
  article-title: Histone demethylation by a family of JmjC domain-containing proteins
  publication-title: Nature
  doi: 10.1038/nature04433
– volume: 353
  start-page: 2643
  year: 2005
  ident: 2022031209283954800_B2
  article-title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa052187
– volume: 13
  start-page: 285
  year: 2004
  ident: 2022031209283954800_B9
  article-title: Limited capacity of the nuclear matrix to bind telomere repeat binding factor TRF1 may restrict the proliferation of mortal human fibroblasts
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddh032
– volume: 100
  start-page: 13567
  year: 2003
  ident: 2022031209283954800_B10
  article-title: Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1834876100
– volume: 25
  start-page: 15
  year: 2007
  ident: 2022031209283954800_B15
  article-title: Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2006.12.014
– volume: 359
  start-page: 1618
  year: 2008
  ident: 2022031209283954800_B4
  article-title: UKPDS and the legacy effect
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe0807625
– volume: 103
  start-page: 568
  year: 2008
  ident: 2022031209283954800_B8
  article-title: An epigenetic clue to diabetic vascular disease
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.184358
– volume: 106
  start-page: 246
  year: 2002
  ident: 2022031209283954800_B11
  article-title: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000021122.63813.32
– volume: 93
  start-page: 225
  year: 1989
  ident: 2022031209283954800_B31
  article-title: Spontaneous recovery of streptozotocin diabetes in mice
  publication-title: Exp Clin Endocrinol
  doi: 10.1055/s-0029-1210861
– volume: 31
  start-page: 390
  year: 1988
  ident: 2022031209283954800_B32
  article-title: In vivo assessment of isolated pancreatic islet viability using the streptozotocin-induced diabetic nude rat
  publication-title: Diabetologia
  doi: 10.1007/BF02341509
– reference: 17525381 - Circ Res. 2007 May 25;100(10):1415-27
– reference: 16732292 - Nature. 2006 Jul 20;442(7100):312-6
– reference: 17434129 - Mol Cell. 2007 Apr 13;26(1):89-101
– reference: 14570951 - JAMA. 2003 Oct 22;290(16):2159-67
– reference: 17410086 - Nat Struct Mol Biol. 2007 Apr;14(4):252-4
– reference: 16362057 - Nature. 2006 Feb 16;439(7078):811-6
– reference: 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53
– reference: 17218268 - Mol Cell. 2007 Jan 12;25(1):15-30
– reference: 16603237 - Cell. 2006 May 5;125(3):483-95
– reference: 18688044 - Circ Res. 2008 Sep 12;103(6):615-23
– reference: 15023892 - Circulation. 2004 Mar 30;109(12):1536-42
– reference: 12105166 - Circulation. 2002 Jul 9;106(2):246-53
– reference: 18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59
– reference: 18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72
– reference: 16630806 - Cell. 2006 Apr 21;125(2):213-7
– reference: 3138150 - Diabetologia. 1988 Jun;31(6):390-4
– reference: 2528469 - Exp Clin Endocrinol. 1989 May;93(2-3):225-30
– reference: 16107577 - J Am Soc Nephrol. 2005 Oct;16(10):2976-84
– reference: 16079795 - Nature. 2005 Sep 15;437(7057):436-9
– reference: 12540855 - Nature. 2003 Feb 6;421(6923):652-6
– reference: 15620353 - Cell. 2004 Dec 29;119(7):941-53
– reference: 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89
– reference: 2296596 - Proc Natl Acad Sci U S A. 1990 Jan;87(1):404-8
– reference: 18796642 - Circ Res. 2008 Sep 12;103(6):568-70
– reference: 16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53
– reference: 18809715 - J Exp Med. 2008 Sep 29;205(10):2409-17
– reference: 14597713 - Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13567-72
– reference: 12700765 - Nature. 2003 Apr 17;422(6933):735-8
– reference: 14681297 - Hum Mol Genet. 2004 Feb 1;13(3):285-93
– reference: 15734862 - Diabetes. 2005 Mar;54(3):830-7
– reference: 18843126 - N Engl J Med. 2008 Oct 9;359(15):1618-20
– reference: 11779497 - Mol Cell. 2001 Dec;8(6):1207-17
SSID ssj0006060
Score 2.4918358
Snippet Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the...
Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more...
OBJECTIVE--Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC)...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1229
SubjectTerms Amino acids
Animals
Biological and medical sciences
Cattle
Complications and side effects
Diabetes
Diabetes. Impaired glucose tolerance
Diabetic Angiopathies - genetics
DNA binding proteins
DNA Methylation
DNA Primers
DNA, Complementary - genetics
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Endothelium, Vascular - physiology
Enzymes
Epidemiology
Epigenetics
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Genetic aspects
Genetic Predisposition to Disease
Genetic transcription
Glucose
Histone-Lysine N-Methyltransferase - genetics
Histone-Lysine N-Methyltransferase - metabolism
Humans
Hyperglycemia
Hyperglycemia - complications
Hyperglycemia - enzymology
Hyperglycemia - genetics
Hyperglycemia - pathology
Lysine - metabolism
Medical sciences
Methyltransferases
Original
Peptides
Physiological aspects
Proteins
Reverse Transcriptase Polymerase Chain Reaction
RNA - genetics
RNA - isolation & purification
Transcription (Genetics)
Title Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail
URI http://diabetes.diabetesjournals.org/content/58/5/1229.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19208907
https://www.proquest.com/docview/216491219
https://www.proquest.com/docview/67179326
https://pubmed.ncbi.nlm.nih.gov/PMC2671038
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgV0JcEG_KLsVCq4VLtI6d5wkt3S4V2i4IdUVvluM4baU2KU16KH-JP8lMXiWo4lK18ii1PZ7JN_b4G0LOHMExFwFiE8Niy_EVbjRpZTFuROQlseBlbcDxrTe6c75M3Wmdm5PXaZWNTywddZxp3CO_4IDrQxvs6-P6p4VFo_Bwta6gcZ8cI3MZZnT50zbeYoDNqxsoNkcWTr8iFuJC-BdxhKymXsmNuH8dNU65YQrGREmVw1wlVZGLQyj032TKv95O14_JoxpW0stqHTwh90z6lDwY1wfnz8jvEcSbm9lyp81qoSgW7AAHQRW9qirS00GWrc2mriVBs4SW_CGpoWMDqgSIbahKY3plVu3vYfprt4KHNBo2Mf2xKOYUmaytS13VTUtndLhGxk-8LEnxZlBOJ3NVwB8iCWdBs5QCBqU3O0zApxO1WD4nd9fDyWBk1XUaLA14prA0ROehNtxWPDKJCJgX8CQC7GgH2nMRg3muAs15QWRcMMrYMa7QEJvp0Ba28cQLcpTCiF4RGhuG6W-OZiJ04pgrzbQfGQVAIrEZUz3yoVGX1DWJOdbSWEoIZlCzEjUrUbM98q4VXVfMHYeEzlHnEpkwUky10dV2jYTxDb5K5AR2AMMFAp7WFZypbZ7L4PNNR-h9LZRk0Cut6isOMDZk2epInnckZxXH-CHB044gGL_uNJ81i1U2m_X7L24gXWlzHvZIv7OQ2wlBnnofdNQjJ83KlrUTy2Vrcj3ytm3FDmBeXmqybS49Hx08h3l8WVnBfqpDzoKQ-T3id-yjFUBe825LupiX_OYcnspE8Pq_fTohD6uDPcw9PSVHxWZr3gA-LKJ-6QXgMxjYfXL8aXj77fsfkvdptg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviG_KxmahMXiJltj5fEBotB0dawtCndibcRynrdQmpWmFyr-E-B-5az5K0MTb3lr55Ni-8_nOvvsdIUc2ZxiLAL6JNiPD9iReNClpmEzz0I0jzja1AfsDt3tpf7xyrnbI7zIXBsMqS524UdRRqvCO_ISBXR9YsL_ezb8bWDQKH1fLChq5VFzo9Q_w2LK3521g7yvGzjrDVtcoigoYCg7fpaHAlQyUZpZkoY65b7o-i0MwdCxfuQ4aDK4j4TOuH2oHJCiytcMVOBIqsLilXQ793iK7NgdPpkF233cGn79Uqh-8gTznxWKI--nlUEaMc-8kChFH1d2gMW4PwPIYKLGJMTRTZsCdOC-rcZ3d-2_45l_n4dl9cq8wZOlpLnkPyI5OHpLb_eKp_hH51QUPdzGarpWeTSTFEiGgkqik7XUiZxNFW2k614uiegVNY7pBLEk07WsQHjDqNZVJRNt6Vv3vJD_XM-iklCkd0a-T5ZgidrZxqvJKbcmIduaIMYrpmRRzkTI6HMslfBBhP5c0TShYvbS3xpB_OpST6WNyeSNMfEIaCczoGaGRNjHgzlYmD-woYlKZygu1BNMltkxTNsmbkl1CFbDpWL1jKsB9Qs4K5KxAzjbJy4p0nmOFXEd0jDwXiL2RYHCPyi-IBMyv9UkgCrENVqPPobc64Uiuskz4H3o1otcFUZzCqJQskipgbojrVaM8rlGOclTz6wj3a4SgblSt-agUVlE-D2x_OL5whMVY0CQHNUGuFgSR8T3gUZPslZItCrWZiWqTN8lh1YoDwEjARKerTLgeHikM1vFpvgu2Sx0w0w9Mr0m82v6oCBBJvd6STMYbRHUGvZrcf_7fMR2SO91hvyd654OLPXI3f1bEyNd90lguVvoFWKfL8KDQCZR8u2k19Afio6Ou
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKkSouiDehpbVQKVxW2bX3eUCoyoOUJoVDKnpzvV5vEinZDdlEKPwlfgH_jpnsIyyKuPWWyCOv7RmPZ-yZbwg5tTnDWATwTbQZGbYn8aJJScNkmoduHHG2qQ04uHJ71_bnG-dmj_wuc2EwrLLUiRtFHaUK78ibDOz6wIL91YyLqIiv7e7H-XcDC0jhQ2tZTSOXkEu9_gHeW_bhog2sfstYtzNs9YyiwICh4CBeGgrcykBpZkkW6pj7puuzOASjx_KV66Dx4DoSPun6oXZAmiJbO1yBU6ECi1va5dDvPXLf446FW8y7qXw9E_yCPPvFYogA6uWgRoxzrxmFiKjqbnAZt0dheSCUKMUYpCkz4FOcF9jYZQH_G8j518nYfUQeFiYtPc9l8DHZ08kTcjAoHu2fkl898HUXo-la6dlEUiwWAsqJStpeJ3I2UbSVpnO9KOpY0DSmG-ySRNOBBjEC815TmUS0rWfV_07ycz2DTkrp0hH9NlmOKaJoG-cqr9mWjGhnjmijmKhJMSspo8OxXMIHEQB0SdOEgv1L-2sM_qdDOZk-I9d3wsLnZD-BGb0kNNImht7ZyuSBHUVMKlN5oZZgxMSWacoGeV-yS6gCQB3reEwFOFLIWYGcFcjZBnlTkc5z1JBdRGfIc4EoHAkKtMqvigTMr_VFIB6xDfajz6G3OuFIrrJM-J_6NaJ3BVGcwqiULNIrYG6I8FWjPKtRjnJ8812ERzVCUDyq1nxaCqsoHwq2PxxfOMJiLGiQ45ogVwuCGPke8KhBDkvJFoUCzUS13RvkpGrFAWBMYKLTVSZcDw8XBuv4It8F26UOmOkHptcgXm1_VASIqV5vSSbjDbY6g15N7r_675hOyAEoH9G_uLo8JA_y90UMgT0i-8vFSr8GM3UZHm8UAiW3d62B_gCLd6Z-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperglycemia+Induces+a+Dynamic+Cooperativity+of+Histone+Methylase+and+Demethylase+Enzymes+Associated+With+Gene-Activating+Epigenetic+Marks+That+Coexist+on+the+Lysine+Tail&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Brasacchio%2C+Daniella&rft.au=Okabe%2C+Jun&rft.au=Tikellis%2C+Christos&rft.au=Balcerczyk%2C+Aneta&rft.date=2009-05-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=58&rft.issue=5&rft.spage=1229&rft_id=info:doi/10.2337%2Fdb08-1666&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1777478541
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon